(Q35184917)

7 August 2017

1 reference

title

Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force (English)

1 reference

7 August 2017

Michael Pignone

2

0 references

author name string

Stacey Sheridan

series ordinal

1

1 reference

7 August 2017

Katrina Donahue

series ordinal

3

1 reference

7 August 2017

publication date

1 August 2003

1 reference

American Journal of Preventive Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

25

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

151-158

1 reference

Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Current methods of the US Preventive Services Task Force: a review of the process

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Prognostic value of systolic and diastolic blood pressure in treated hypertensive men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

The rational clinical examination. Does this patient have hypertension? How to measure blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

The effect of alternative criteria for hypertension on estimates of prevalence and control

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Canadian hypertension society guidelines for ambulatory blood pressure monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

The prognostic value of ambulatory blood pressures.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Body weight and blood pressure. Effects of weight reduction on hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Systematic review of long term effects of advice to reduce dietary salt in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Randomized trials of sodium reduction: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

The psychological effect of a screening programme and clinical trial for hypertension upon the participants

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Consequences of worksite hypertension screening. Differential changes in psychosocial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Consequences of worksite hypertension screening. Changes in absenteeism

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Work absenteeism and well-being in patients treated for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Disability days associated with detection and treatment in a hypertension control program

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Increased absenteeism from work after detection and labeling of hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Absenteeism and labelling in hypertensive subjects. Prevention of an adverse impact in those at high risk

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of labelling on income, work and social function among hypertensive employees

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Occupationally-sponsored, community-provided hypertension control

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Effects of labeling and treatment of hypertension on perceived health

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2803%2900121-1

7 January 2021

10.1016/S0749-3797(03)00121-1

Identifiers

DOI

1 reference

7 August 2017

1 reference